Publikace
- Development of submicromolar 17 beta-HSD10 inhibitors and their in vitro and in vivo evaluation2023 | 1. lékařská fakulta
- Pursuing the Complexity of Alzheimer's Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and N-Methyl-D-Aspartate Receptor Antagonists2021 | Farmaceutická fakulta v Hradci Králové, Přírodovědecká fakulta
- Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease2021 | Publikace bez příslušnosti k fakultě
- Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase2020 | Farmaceutická fakulta v Hradci Králové
- Novel sustainable-by-design HDAC inhibitors for the treatment of Alzheimer's disease2019 | Publikace bez příslušnosti k fakultě
- Current approaches to enhancing oxime reactivator delivery into the brain2019 | Publikace bez příslušnosti k fakultě
- Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease2019 | Publikace bez příslušnosti k fakultě
- Tacroximes: novel unique compounds for the recovery of organophosphorus-inhibited acetylcholinesterase2019 | Publikace bez příslušnosti k fakultě
- Differentiated SH-SY5Y neuroblastoma cells as a model for evaluation of nerve agent-associated neurotoxicity2023 | Farmaceutická fakulta v Hradci Králové, 1. lékařská fakulta
- Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation2023 | Farmaceutická fakulta v Hradci Králové
Loading network view...
